Closed System Drug Transfer Device Market Sales Revenue, Emerging Technologies and Growth Analysis By 2025
Market Key Players Teva Pharmaceutical Industries Ltd. (Israel), Becton, Dickinson and Company (U.S.) Corvida Medical (U.S.) ICU Medical Inc. (U.S.) Yukon Medical (U.S.) Equashield LLC (U.S.) The global closed system drug transfer device (CSTD) market size is poised to expand at 19.10% CAGR over the forecast period (2018–2025). The market is driven by the prevalence of cancer cases globally. According to the Canadian Cancer Society in 2017, nearly 206, 200 instances were registered with 80,800 dying from the disease. CSTDs are required for protecting hospital staff from hazardous drugs and ensuring their safety. Furthermore, safety guidelines outlined by regulatory bodies for safe handling practices at hospitals and clinics is predicted to augur well for the closed system drug transfer device market . Segmentation Analysis The closed system drug transfer device (CSTD) market is segmented by type, delivery, and end-user. By type, barrier-type was the larges...